Charles Sherwood
Director/Board Member at ZEA Biosciences Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bernat Olle | M | - |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 14 years |
| Jeffery Thompson | M | 58 | 13 years | |
| Troy Ignelzi | M | 56 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 4 years |
| James Wilson | M | - |
ZEA Biosciences Corp.
 ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | 6 years |
| Ben Shapiro | M | 84 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 14 years |
| Glenn Larsen | M | 70 | 9 years | |
| John LaMattina | M | 74 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 12 years |
| Kenya Honda | M | - |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 14 years |
| Charles Legg | M | - |
ZEA Biosciences Corp.
ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | - |
| Neil Tiwari | M | 37 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | - |
| Foster Chase | M | - |
ZEA Biosciences Corp.
ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | - |
| Arlene Powers | F | - |
ZEA Biosciences Corp.
ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | 6 years |
| Alexander Rudensky | M | - |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 14 years |
| Daniel Couto | M | 52 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | - |
| Susan Dillon | M | - |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | - |
| Dan Littman | M | 71 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 14 years |
| Curt LaBelle | M | 53 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 1 years |
| Martin Heidecker | M | - |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | - |
| Barton Finlay | M | - |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 14 years |
| James L. Holbrook | M | 64 |
ZEA Biosciences Corp.
ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | 5 years |
| Jeremiah Faith | M | - |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kevin W. Quinlan | M | 74 | 8 years | |
| Sylvia Cheung | F | 50 | 15 years | |
| Francesco J. Luppino | M | 55 | 16 years | |
| J. Engle | M | 74 | 5 years | |
| Joseph G. Darling | M | 66 | 3 years | |
| David R. Morrison | M | 79 |
Chiron Vision Corp.
| 3 years |
| Randall W. Wilhoite | M | 58 | - | |
| Jill A. Wollins | M | - | - | |
| Edward Gaj | M | 67 | 14 years | |
| John C. Moran | M | 71 | 9 years | |
| Irina B. Kulinets | M | 69 | 5 years | |
| Steven J. Chartier | M | 55 | 1 years | |
| Raymond J. Land | M | 79 | 16 years | |
| Carol Pekar | F | - | - | |
| James E. O'Neill | M | 60 | - | |
| Stephen R. Mascioli | M | 69 | 1 years | |
| Christopher Ranjitkar | M | - | 1 years | |
| Dana M. Alexander | M | 47 | 2 years | |
| Jing-Wen Kuo | M | - | 2 years | |
| Thomas J. Chambers | M | - | - | |
| Jean Bjerke | F | - | 1 years | |
| Ellen MacKenzie | F | - | - | |
| Richard Hague | M | 63 | 4 years | |
| Edward S. Ahn | M | 51 | 5 years | |
| Thomas Finnerty | M | 66 | - | |
| Thomas Burns | M | 63 |
Chiron Vision Corp.
| 7 years |
| John W. Sheets | M | 70 | 1 years | |
| Alessandra Pavesio | F | 57 | 1 years | |
| Steven Cyr | M | - | - | |
| Gregory T. Fulton | M | 68 | - | |
| Sean Moran | M | 66 | 7 years | |
| Carol A. Barnett | F | 59 | 2 years | |
| William J. Mrachek | M | 80 | - | |
| Samuel F. McKay | M | - | - | |
| Harvey S. Sadow | M | - | - | |
| David F. Heniges | M | 80 |
Iolab Corp.
| 13 years |
| Donald Middlebrook | M | 73 |
Chiron Vision Corp.
| 1 years |
| William J. Knight | M | 74 | 2 years | |
| Andrew Carter | M | 68 | - | |
| Constance H. Garrison | F | - | - | |
| Michael R. Slater | M | 77 | 3 years | |
| Donald Duffy | M | 87 |
Iolab Corp.
| 5 years |
| Michael Joseph O'Rourke | M | - |
Chiron Vision Corp.
| 3 years |
| Eugene A. Davidson | M | 93 | 18 years | |
| David John Bailey | M | 75 |
Chiron Vision Corp.
| 4 years |
| Michael Alfieri | M | 59 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 67 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles Sherwood
- Personal Network
